cysteine has been researched along with Degenerative Diseases, Central Nervous System in 63 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (1.59) | 18.2507 |
2000's | 23 (36.51) | 29.6817 |
2010's | 21 (33.33) | 24.3611 |
2020's | 18 (28.57) | 2.80 |
Authors | Studies |
---|---|
Ábrányi-Balogh, P; Davis, B; Imre, T; Juhász, T; Keserű, GM; Mándity, I; Petri, L; Rácz, A; Tóth, EZ; Tóth, K; Vagrys, D; Varró, N; Wittner, L | 1 |
Hu, Z; Liu, X; Ni, G; Wang, Z; Yan, Z; Yang, G; Zhang, M; Zhang, Y | 1 |
Lomont, JP; Smith, JP | 1 |
Cho, EJ; Eom, JW; Kim, KR; Kim, YH; Lipton, SA; Nakamura, T; Oh, CK; Oh, SS | 1 |
Paul, BD | 1 |
Chang, L; Dai, T; Ma, B; Ma, F; Mao, Y; Mei, Q; Shen, Z; Wang, Z; Xin, X; Zhu, Y | 1 |
Bretonnière, Y; Girod, M; Guillaubez, JV; Lemoine, J; Pitrat, D | 1 |
Coen, M; Foster, E; Martins, LM; Michopoulos, F; Popovic, R; Travaglio, M; Yu, Y | 1 |
Deng, Y; Liu, H; Liu, W; Wang, C; Xu, B; Xu, S; Yang, T | 1 |
Nakanishi, H; Stoka, V; Turk, V; Vasiljeva, O | 1 |
Abdillah, A; Churchill, DG; Kim, Y; Lee, W; Mulay, SV; Palma, J; Shimodaira, S; Yudhistira, T | 1 |
Mano, N; Ogura, J; Ruddock, LW | 1 |
Han, F; Lin, W; Ma, Y; Min, J | 1 |
Chatterji, A; Sengupta, R | 1 |
Aoyama, K; Kinoshita, C; Matsumura, N | 1 |
Kung, WM; Lin, MS | 1 |
Anand, BG; Brünnert, D; Goyal, P; Hanschmann, EM; Kar, K; Kateriya, S; Kaushik, V; Sharma, PK | 1 |
Castiglioni, L; Colazzo, F; Gelosa, P; Sironi, L; Tremoli, E | 1 |
Arjune, S; Ayton, S; Belaidi, AA; Bush, AI; Dejanovic, B; Fusca, D; Hetsch, F; Kloppenburg, P; Kumar, A; Meier, JC; Santamaria-Araujo, JA; Schwarz, G; Semtner, M; Winkelmann, A | 1 |
Paul, BD; Sbodio, JI; Snyder, SH | 2 |
Hamada, K; Ishii, K; Iwata, A; Mannen, T; Murayama, S; Saito, Y; Sakurai, Y; Sonoo, M; Sugimoto, I; Tsuji, S | 1 |
Gerszon, J; Puchała, M; Rodacka, A | 1 |
Ho, SC; Su, MS | 1 |
Lee, TH; Yang, HY | 1 |
Gorelenkova Miller, O; Mieyal, JJ | 1 |
Aslan, M; Griffiths, HR; McBean, GJ; Torrão, RC | 1 |
Lee, JC; McGlinchey, RP | 1 |
Greenlief, CM; Gu, Z; Qu, Z | 1 |
Asada, T; Hara, T; Hashimoto, S; Iwasaka, A; Nemoto, H; Nemoto, K | 1 |
Gu, L; Robinson, RA | 1 |
Diblik, P; Hlusicka, J; Kacer, P; Kotikova, K; Kuthan, P; Navratil, T; Nurieva, O; Pelclova, D; Seidl, Z; Urban, P; Vaneckova, M; Zakharov, S | 1 |
Aoyama, K; Nakaki, T; Watabe, M | 1 |
Cappai, R; Coleman, BM; Han, S; Hatters, DM; Hill, AF; Nisbet, RM | 1 |
Elinos-Calderón, D; Galván-Arzate, S; Maldonado, PD; Pedraza-Chaverrí, J; Pérez-De La Cruz, V; Robledo-Arratia, Y; Santamaría, A | 1 |
Chung, KK | 1 |
Sawa, A; Shahani, N | 1 |
Becker, EB; Bitoun, E; Butts, DL; Cheeseman, MT; Davies, B; Davies, KE; Edwards, B; Finelli, MJ; Oliver, PL | 1 |
Abe, K; Deguchi, K; Deguchi, S; Ikeda, Y; Kametaka, S; Kurata, T; Manabe, Y; Morimoto, N; Ohta, T; Ohta, Y; Sato, S; Takao, Y | 1 |
Chang, CF; Chang, CK; Chiang, MH; Huang, TH; Toh, EK | 1 |
Drozak, J; Winiarska, K | 1 |
Hossain, AK; Matsushima, E; Mizusawa, H; Murata, Y; Oda, K; Okubo, Y; Saitoh, Y; Shibuya, H; Taura, S; Zhang, L | 1 |
Blom, HJ; Bosma, H; Bosmans, E; De Bruijn, C; de Vente, J; Delanghe, J; Lütjohann, D; Maes, M; Rieckmann, P; Steinbusch, HW; Teunissen, CE; van Boxtel, MP; Verbeek, MM; Verhey, F; von Bergmann, K; Vreeling, F; Wauters, A | 1 |
Chen, J; Der-Sarkissian, A; Jao, CC; Langen, R | 1 |
Bar-Am, O; Fridkin, M; Gal, S; Warshawsky, A; Weiner, LM; Youdim, MB; Zheng, H | 1 |
Cumming, RC; Schubert, D | 1 |
Chung, KK; Dawson, TM; Dawson, VL | 1 |
Hori, S; Kakizuka, A; Kimura, Y; Koike, M; Manno, A; Murakami, K; Noguchi, M; Ohizumi, H; Takata, T | 1 |
Battisti, C; Cardaioli, E; Cerase, A; Da Pozzo, P; De Stefano, N; Dotti, MT; Federico, A; Malandrini, A; Sicurelli, F; Stromillo, ML | 1 |
Abe, K; Kawarabayashi, T; Matsubara, E; Nagano, I; Shoji, M | 1 |
Eisenberg, D; Guo, Z | 1 |
Gu, Z; Lipton, SA; Ma, Y; Masliah, E; Nakamura, T; Nomura, Y; Shi, ZQ; Uehara, T; Yao, D | 1 |
Browndyke, J; Ghio, A; Schmechel, DE | 1 |
Decary, A; Gravel, P; Massicotte-Marquez, J; Mazza, S; Michaud, M; Montplaisir, J; Postuma, R; Soucy, JP | 1 |
Satoh, T | 1 |
Becker, G; Fassbender, K; Herrmann, W; Kasoha, M; Knapp, JP; Kostopoulos, P; Obeid, R | 1 |
Fairlie, DP; Harrison, RS; Sharpe, PC; Singh, Y | 1 |
Sarkar, DP; Sinha, S; Surolia, I | 1 |
Barthel, H; Burchert, W; Dannenberg, C; Kämpfer, I; Kluge, R; Knapp, WH; Seese, A | 1 |
Rouault, TA | 1 |
Hayes, EL; Kanterewicz, BI; Klann, E; Knapp, LT | 1 |
Dringen, R; Gros, C; Gutterer, JM; Hirrlinger, J | 1 |
23 review(s) available for cysteine and Degenerative Diseases, Central Nervous System
Article | Year |
---|---|
Cysteine Donor-Based Brain-Targeting Prodrug: Opportunities and Challenges.
Topics: Animals; Antioxidants; Biological Transport; Blood-Brain Barrier; Cysteine; Excitatory Amino Acid Transporter 3; Glutathione; Humans; Neurodegenerative Diseases; Oxidative Stress; Permeability; Prodrugs; Signal Transduction | 2022 |
Cysteine metabolism and hydrogen sulfide signaling in Huntington's disease.
Topics: Cystathionine gamma-Lyase; Cysteine; Humans; Huntington Disease; Hydrogen Sulfide; Neurodegenerative Diseases; Signal Transduction | 2022 |
Ferroptosis and Neurodegenerative Diseases: Insights into the Regulatory Roles of SLC7A11.
Topics: Amino Acid Transport System y+; Apoptosis; Cysteine; Ferroptosis; Humans; Iron; Neurodegenerative Diseases | 2023 |
Effect of 12-week of aerobic exercise on hormones and lipid profile status in adolescent girls with polycystic ovary syndrome: A study during COVID-19.
Topics: Actin Cytoskeleton; Actins; Adaptor Proteins, Signal Transducing; Adenocarcinoma; Adenosine Triphosphate; Adsorption; Adult; Africa, Eastern; Aged; Air Pollutants; Air Pollution; Air Pollution, Indoor; Alcohol Drinking; Allergens; Alzheimer Disease; Amyotrophic Lateral Sclerosis; Animals; Anti-Bacterial Agents; Antibodies; Antibodies, Immobilized; Antigen Presentation; Antigens, CD; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Apoptosis; Aptamers, Nucleotide; Asthma; Asthma, Exercise-Induced; Atrophy; Autophagy; Azoospermia; Bacillus cereus; Bacterial Infections; Beclin-1; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Biofouling; Biological Monitoring; Biomarkers; Biomarkers, Tumor; Biosensing Techniques; Blastocyst; Bone Neoplasms; Bone Regeneration; Bronchoconstriction; Burkitt Lymphoma; C9orf72 Protein; Campylobacter; Campylobacter Infections; Campylobacter jejuni; Carcinogenesis; Carcinoma, Hepatocellular; Carcinoma, Pancreatic Ductal; Carcinoma, Squamous Cell; Cardiomyopathies; Caregivers; Carmine; Case-Control Studies; Catalysis; Cattle; Cause of Death; CCAAT-Enhancer-Binding Protein-alpha; CD8-Positive T-Lymphocytes; Cefepime; Cell Differentiation; Cell Line, Tumor; Cell Nucleus; Cell Transdifferentiation; Chelating Agents; Chemical and Drug Induced Liver Injury, Chronic; Chemoradiotherapy, Adjuvant; Child; Child, Preschool; China; Chlorquinaldol; Cholangiocarcinoma; Cholera; Chromatin; Clinical Trials as Topic; Cognitive Dysfunction; Cohort Studies; Colonic Neoplasms; Colorectal Neoplasms; Colorimetry; Cooking; Coordination Complexes; COVID-19; Creatinine; CRISPR-Cas Systems; Critical Care; Critical Illness; Cross-Sectional Studies; Cryopreservation; Cryoprotective Agents; Cysteine; Cytokines; Device Removal; Diet; Diet, High-Fat; Diet, Mediterranean; Dietary Supplements; Dimethyl Sulfoxide; Dipeptides; Disease Models, Animal; Dithiothreitol; DNA; DNA Repeat Expansion; DNA, Bacterial; DNA, Complementary; Dopamine; Electrochemical Techniques; Electrodes; Endocannabinoids; Environmental Exposure; Environmental Monitoring; Environmental Pollutants; Enzyme-Linked Immunosorbent Assay; Erlotinib Hydrochloride; Escherichia coli; Escherichia coli O157; Esophageal Neoplasms; Esophagitis, Peptic; Ethylene Glycol; Europium; Exanthema; Fallopian Tubes; Feces; Female; Fertilization in Vitro; Fluoresceins; Fluorescent Dyes; Follicle Stimulating Hormone; Follow-Up Studies; Food Microbiology; Forced Expiratory Volume; Forkhead Transcription Factors; Frontotemporal Dementia; G-Quadruplexes; Galactose; Gastroenteritis; Gastrointestinal Diseases; Gastrointestinal Microbiome; Gastrointestinal Neoplasms; Gastrointestinal Tract; Gene Frequency; Genetic Association Studies; Genetic Predisposition to Disease; Genital Neoplasms, Female; Genome-Wide Association Study; Genome, Viral; Genomics; Genotype; Glucose; Glutathione; Glycerol; Gold; Graphite; GTPase-Activating Proteins; Heat-Shock Proteins; Heme Oxygenase-1; Hepacivirus; Hepatitis C; Hepatocytes; Histamine; Histocompatibility Antigens Class II; Hoarseness; Hospice and Palliative Care Nursing; Humans; Hydrogen; Hydrogen Peroxide; Hydrogen Sulfide; Hydroxybenzoates; Hydroxyl Radical; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperthermia, Induced; Hysteroscopy; Immunoassay; Indigo Carmine; Inflammation; Inflammatory Bowel Diseases; Insulin Resistance; Intensive Care Units; Interleukin-11; Interleukin-6; Interleukins; Iodine Radioisotopes; Iran; Iridium; Islets of Langerhans; Kinetics; Lactation; Lactobacillus; Lactobacillus plantarum; Lamins; Latin America; Lead; Lectins; Leukopenia; Ligands; Limit of Detection; Lipopolysaccharides; Lipoprotein Lipase; Liver; Liver Cirrhosis; Liver Neoplasms; Lolium; Luminescent Measurements; Luminol; Lung; Luteinizing Hormone; Macrophages; Magnetic Phenomena; Magnetic Resonance Imaging; Male; Malnutrition; Maltose; Manganese Compounds; Maternal Nutritional Physiological Phenomena; Melatonin; Metabolic Engineering; Metal Nanoparticles; Metallocenes; Metaplasia; Methicillin-Resistant Staphylococcus aureus; Methylation; Mevalonic Acid; Mexico; Mice; Mice, Inbred C57BL; Mice, Transgenic; Microbial Sensitivity Tests; Microbiota; MicroRNAs; Milk; Mitomycin; Molecular Diagnostic Techniques; Molecular Docking Simulation; Monte Carlo Method; Moringa oleifera; Multiple Sclerosis; Muscle Strength; Muscle, Skeletal; Nanocomposites; Nanotubes, Carbon; Neoadjuvant Therapy; Neoplasms; Neurodegenerative Diseases; Neurotransmitter Agents; NF-E2-Related Factor 2; Nickel; Nitrogen Dioxide; Non-alcoholic Fatty Liver Disease; Nucleic Acid Amplification Techniques; Nucleic Acid Hybridization; Nucleocapsid Proteins; Nutritional Status; Obesity; Osteogenesis; Osteosarcoma; Oxidation-Reduction; Oxides; Oxygen; Oxyquinoline; Pain; Palliative Care; Pancreatic Neoplasms; Pandemics; Particulate Matter; Peroxidase; Peroxidases; Phagocytosis; Phaseolus; Photothermal Therapy; Point-of-Care Systems; Polyethyleneimine; Polymers; Polymorphism, Single Nucleotide; Polysomnography; Postoperative Complications; Pregnancy; Pregnant Women; Prenatal Exposure Delayed Effects; Prevalence; Printing, Three-Dimensional; Probability; Probiotics; Prognosis; Prophages; Prospective Studies; Proteomics; Proto-Oncogene Proteins; Pseudomonas aeruginosa; Pseudomonas putida; Pulmonary Disease, Chronic Obstructive; Pulmonary Embolism; Pyridines; Pyrroles; Quality of Life; Quinolones; Rabbits; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Real-Time Polymerase Chain Reaction; Receptors, Histamine; Receptors, Histamine H2; Recombinases; Rectal Neoplasms; Reperfusion Injury; Respiration; Respiratory Function Tests; Respiratory Rate; Respiratory Sounds; Retrospective Studies; rho GTP-Binding Proteins; Risk Assessment; Risk Factors; RNA; RNA, Messenger; RNA, Ribosomal, 16S; Robotic Surgical Procedures; Running; Rural Population; Saccharomyces cerevisiae; Salpingectomy; Sarcopenia; SARS-CoV-2; Seeds; Semen; Sensitivity and Specificity; Sepsis; Shock, Septic; Signal Transduction; Silicon Dioxide; Silver; Sirtuin 1; Skin Neoplasms; Sleep Apnea, Obstructive; Soil; Spain; Spectrum Analysis, Raman; Sperm Retrieval; Spermatozoa; Spirometry; Staphylococcus aureus; STAT3 Transcription Factor; Stereoisomerism; Sterilization, Tubal; Stroke Volume; Sulfadiazine; Sulfites; Superoxide Dismutase; Surface Plasmon Resonance; tau Proteins; Testis; Testosterone; Thioredoxin-Disulfide Reductase; Thyroid Neoplasms; Thyroidectomy; Trans-Activators; Transcription Factor AP-1; Treatment Outcome; Triazoles; Triclosan; Trifluridine; Tumor Microenvironment; Tumor Necrosis Factor-alpha; United States; Uracil; Vagina; Vegetables; Ventricular Function, Left; Ventricular Pressure; Vibrio cholerae; Vietnam; Virulence; Vital Capacity; Vitrification; Walking; Water; Water Pollutants, Radioactive; Whole Genome Sequencing; Wind; YAP-Signaling Proteins; Zeolites; Zinc Oxide | 2023 |
The Role of Cysteine Protease Cathepsins B, H, C, and X/Z in Neurodegenerative Diseases and Cancer.
Topics: Cathepsin B; Cysteine; Cysteine Proteases; Humans; Lysosomes; Neoplasms; Neurodegenerative Diseases | 2023 |
Cellular S-denitrosylases: Potential role and interplay of Thioredoxin, TRP14, and Glutaredoxin systems in thiol-dependent protein denitrosylation.
Topics: Cardiovascular Diseases; Cysteine; Gene Expression Regulation; Glutaredoxins; Humans; Immune System Diseases; Neoplasms; Neurodegenerative Diseases; Nitric Oxide; Nitrosation; Nitrosative Stress; Oxidation-Reduction; S-Nitrosothiols; Signal Transduction; Substrate Specificity; Thioredoxins | 2021 |
The NFκB Antagonist CDGSH Iron-Sulfur Domain 2 Is a Promising Target for the Treatment of Neurodegenerative Diseases.
Topics: Cysteine; Histidine; Homeostasis; Humans; Iron; Iron-Sulfur Proteins; Membrane Proteins; Neurodegenerative Diseases; NF-kappa B; PPAR-beta; Protein Domains | 2021 |
Cysteinyl Leukotrienes as Potential Pharmacological Targets for Cerebral Diseases.
Topics: Animals; Arthritis, Rheumatoid; Cardiovascular Diseases; Central Nervous System Diseases; Cysteine; Dermatitis, Atopic; Humans; Leukotrienes; Neurodegenerative Diseases | 2017 |
Cysteine Metabolism in Neuronal Redox Homeostasis.
Topics: Animals; Autophagy; Cysteine; Glutathione; Homeostasis; Humans; Neurodegenerative Diseases; Neurons; Oxidation-Reduction; Protein Processing, Post-Translational | 2018 |
Redox Mechanisms in Neurodegeneration: From Disease Outcomes to Therapeutic Opportunities.
Topics: Animals; Cysteine; Free Radicals; Humans; Neurodegenerative Diseases; Oxidation-Reduction; Oxidative Stress; Signal Transduction | 2019 |
[The biological significance of oxidative modifications of cysteine residues in proteins illustrated with the example of glyceraldehyde-3-phosphate dehydrogenase].
Topics: Animals; Apoptosis; Cysteine; Endothelin-1; Glyceraldehyde; Glyceraldehyde-3-Phosphate Dehydrogenases; Humans; Neurodegenerative Diseases; Nuclear Proteins; Oxidation-Reduction; Oxidative Stress | 2014 |
Antioxidant enzymes as redox-based biomarkers: a brief review.
Topics: Aging; Alzheimer Disease; Animals; Antioxidants; Biomarkers; Catalysis; Cell Line, Tumor; Cysteine; Enzymes; Glutathione; Hep G2 Cells; Humans; Hypertension, Renal; Neurodegenerative Diseases; Oxidation-Reduction; Oxidative Stress; Oxygen; Peroxiredoxins; Protein Processing, Post-Translational; Proteomics; Reactive Oxygen Species; Reperfusion Injury | 2015 |
Sulfhydryl-mediated redox signaling in inflammation: role in neurodegenerative diseases.
Topics: Animals; Cysteine; Humans; Inflammation; Neurodegenerative Diseases; Oxidation-Reduction; Oxidative Stress; Protein Processing, Post-Translational; Proteins; Signal Transduction; Sulfhydryl Compounds | 2015 |
Thiol redox homeostasis in neurodegenerative disease.
Topics: Cysteine; Glaucoma; Glutaredoxins; Humans; Neurodegenerative Diseases; Neurons; Oxidation-Reduction; Peroxiredoxins; Sulfhydryl Compounds; Thioredoxins | 2015 |
Quantitative Proteomic Approaches for Analysis of Protein S-Nitrosylation.
Topics: Amino Acid Sequence; Animals; Consensus Sequence; Cysteine; Humans; Molecular Sequence Data; Neurodegenerative Diseases; Nitric Oxide; Oxidation-Reduction; Oxidative Stress; Protein Processing, Post-Translational; Proteome; Proteomics; S-Nitrosothiols; Signal Transduction | 2016 |
Proteomic approaches to quantify cysteine reversible modifications in aging and neurodegenerative diseases.
Topics: Aging; Animals; Cysteine; Humans; Neurodegenerative Diseases; Oxidation-Reduction; Protein Processing, Post-Translational; Proteomics | 2016 |
Regulation of neuronal glutathione synthesis.
Topics: Animals; Antioxidants; Cysteine; Disease Models, Animal; Excitatory Amino Acid Transporter 3; Glutamate Plasma Membrane Transport Proteins; Glutathione; Humans; Neurodegenerative Diseases; Neurons; Neuroprotective Agents; Oxidative Stress; Parkinsonian Disorders | 2008 |
Modulation of pro-survival proteins by S-nitrosylation: implications for neurodegeneration.
Topics: Animals; Cysteine; Humans; Neurodegenerative Diseases; Nitric Oxide; Proteins | 2010 |
Protein S-nitrosylation: role for nitric oxide signaling in neuronal death.
Topics: Animals; Caspases; Cell Communication; Cell Death; Central Nervous System; Cysteine; Humans; Neurodegenerative Diseases; Neurons; Nitric Oxide; Nitrosation; Oxidative Stress; Signal Transduction | 2012 |
[Glutathione in therapy].
Topics: Animals; Cysteine; Diabetes Mellitus; Glutathione; Humans; Infections; Neurodegenerative Diseases; Oxidative Stress; Pyrrolidonecarboxylic Acid; Thiazoles; Thiazolidines | 2002 |
Nitric oxide, S-nitrosylation and neurodegeneration.
Topics: Animals; Cysteine; Hemostasis; Humans; Neurodegenerative Diseases; Nitric Oxide; Nitric Oxide Synthase; Nitroso Compounds; Oxidation-Reduction; Oxidative Stress; Oxygen; Parkinson Disease; S-Nitrosothiols; Signal Transduction | 2005 |
[Cysteine-mediated signaling pathway by a novel electrophilic compound, NEPP11].
Topics: Cognition Disorders; Cysteine; Drug Design; Electrons; Neurodegenerative Diseases; Nitric Oxide; Prostaglandin D2; Prostaglandins; Signal Transduction | 2007 |
Amyloid peptides and proteins in review.
Topics: Amyloid; Animals; Cysteine; Humans; Hydrogen-Ion Concentration; Macromolecular Substances; Models, Molecular; Molecular Conformation; Neurodegenerative Diseases; Peptides; Protein Conformation; Protein Folding; Protein Structure, Secondary; Proteins; Static Electricity | 2007 |
2 trial(s) available for cysteine and Degenerative Diseases, Central Nervous System
Article | Year |
---|---|
Effect of 12-week of aerobic exercise on hormones and lipid profile status in adolescent girls with polycystic ovary syndrome: A study during COVID-19.
Topics: Actin Cytoskeleton; Actins; Adaptor Proteins, Signal Transducing; Adenocarcinoma; Adenosine Triphosphate; Adsorption; Adult; Africa, Eastern; Aged; Air Pollutants; Air Pollution; Air Pollution, Indoor; Alcohol Drinking; Allergens; Alzheimer Disease; Amyotrophic Lateral Sclerosis; Animals; Anti-Bacterial Agents; Antibodies; Antibodies, Immobilized; Antigen Presentation; Antigens, CD; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Apoptosis; Aptamers, Nucleotide; Asthma; Asthma, Exercise-Induced; Atrophy; Autophagy; Azoospermia; Bacillus cereus; Bacterial Infections; Beclin-1; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Biofouling; Biological Monitoring; Biomarkers; Biomarkers, Tumor; Biosensing Techniques; Blastocyst; Bone Neoplasms; Bone Regeneration; Bronchoconstriction; Burkitt Lymphoma; C9orf72 Protein; Campylobacter; Campylobacter Infections; Campylobacter jejuni; Carcinogenesis; Carcinoma, Hepatocellular; Carcinoma, Pancreatic Ductal; Carcinoma, Squamous Cell; Cardiomyopathies; Caregivers; Carmine; Case-Control Studies; Catalysis; Cattle; Cause of Death; CCAAT-Enhancer-Binding Protein-alpha; CD8-Positive T-Lymphocytes; Cefepime; Cell Differentiation; Cell Line, Tumor; Cell Nucleus; Cell Transdifferentiation; Chelating Agents; Chemical and Drug Induced Liver Injury, Chronic; Chemoradiotherapy, Adjuvant; Child; Child, Preschool; China; Chlorquinaldol; Cholangiocarcinoma; Cholera; Chromatin; Clinical Trials as Topic; Cognitive Dysfunction; Cohort Studies; Colonic Neoplasms; Colorectal Neoplasms; Colorimetry; Cooking; Coordination Complexes; COVID-19; Creatinine; CRISPR-Cas Systems; Critical Care; Critical Illness; Cross-Sectional Studies; Cryopreservation; Cryoprotective Agents; Cysteine; Cytokines; Device Removal; Diet; Diet, High-Fat; Diet, Mediterranean; Dietary Supplements; Dimethyl Sulfoxide; Dipeptides; Disease Models, Animal; Dithiothreitol; DNA; DNA Repeat Expansion; DNA, Bacterial; DNA, Complementary; Dopamine; Electrochemical Techniques; Electrodes; Endocannabinoids; Environmental Exposure; Environmental Monitoring; Environmental Pollutants; Enzyme-Linked Immunosorbent Assay; Erlotinib Hydrochloride; Escherichia coli; Escherichia coli O157; Esophageal Neoplasms; Esophagitis, Peptic; Ethylene Glycol; Europium; Exanthema; Fallopian Tubes; Feces; Female; Fertilization in Vitro; Fluoresceins; Fluorescent Dyes; Follicle Stimulating Hormone; Follow-Up Studies; Food Microbiology; Forced Expiratory Volume; Forkhead Transcription Factors; Frontotemporal Dementia; G-Quadruplexes; Galactose; Gastroenteritis; Gastrointestinal Diseases; Gastrointestinal Microbiome; Gastrointestinal Neoplasms; Gastrointestinal Tract; Gene Frequency; Genetic Association Studies; Genetic Predisposition to Disease; Genital Neoplasms, Female; Genome-Wide Association Study; Genome, Viral; Genomics; Genotype; Glucose; Glutathione; Glycerol; Gold; Graphite; GTPase-Activating Proteins; Heat-Shock Proteins; Heme Oxygenase-1; Hepacivirus; Hepatitis C; Hepatocytes; Histamine; Histocompatibility Antigens Class II; Hoarseness; Hospice and Palliative Care Nursing; Humans; Hydrogen; Hydrogen Peroxide; Hydrogen Sulfide; Hydroxybenzoates; Hydroxyl Radical; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperthermia, Induced; Hysteroscopy; Immunoassay; Indigo Carmine; Inflammation; Inflammatory Bowel Diseases; Insulin Resistance; Intensive Care Units; Interleukin-11; Interleukin-6; Interleukins; Iodine Radioisotopes; Iran; Iridium; Islets of Langerhans; Kinetics; Lactation; Lactobacillus; Lactobacillus plantarum; Lamins; Latin America; Lead; Lectins; Leukopenia; Ligands; Limit of Detection; Lipopolysaccharides; Lipoprotein Lipase; Liver; Liver Cirrhosis; Liver Neoplasms; Lolium; Luminescent Measurements; Luminol; Lung; Luteinizing Hormone; Macrophages; Magnetic Phenomena; Magnetic Resonance Imaging; Male; Malnutrition; Maltose; Manganese Compounds; Maternal Nutritional Physiological Phenomena; Melatonin; Metabolic Engineering; Metal Nanoparticles; Metallocenes; Metaplasia; Methicillin-Resistant Staphylococcus aureus; Methylation; Mevalonic Acid; Mexico; Mice; Mice, Inbred C57BL; Mice, Transgenic; Microbial Sensitivity Tests; Microbiota; MicroRNAs; Milk; Mitomycin; Molecular Diagnostic Techniques; Molecular Docking Simulation; Monte Carlo Method; Moringa oleifera; Multiple Sclerosis; Muscle Strength; Muscle, Skeletal; Nanocomposites; Nanotubes, Carbon; Neoadjuvant Therapy; Neoplasms; Neurodegenerative Diseases; Neurotransmitter Agents; NF-E2-Related Factor 2; Nickel; Nitrogen Dioxide; Non-alcoholic Fatty Liver Disease; Nucleic Acid Amplification Techniques; Nucleic Acid Hybridization; Nucleocapsid Proteins; Nutritional Status; Obesity; Osteogenesis; Osteosarcoma; Oxidation-Reduction; Oxides; Oxygen; Oxyquinoline; Pain; Palliative Care; Pancreatic Neoplasms; Pandemics; Particulate Matter; Peroxidase; Peroxidases; Phagocytosis; Phaseolus; Photothermal Therapy; Point-of-Care Systems; Polyethyleneimine; Polymers; Polymorphism, Single Nucleotide; Polysomnography; Postoperative Complications; Pregnancy; Pregnant Women; Prenatal Exposure Delayed Effects; Prevalence; Printing, Three-Dimensional; Probability; Probiotics; Prognosis; Prophages; Prospective Studies; Proteomics; Proto-Oncogene Proteins; Pseudomonas aeruginosa; Pseudomonas putida; Pulmonary Disease, Chronic Obstructive; Pulmonary Embolism; Pyridines; Pyrroles; Quality of Life; Quinolones; Rabbits; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Real-Time Polymerase Chain Reaction; Receptors, Histamine; Receptors, Histamine H2; Recombinases; Rectal Neoplasms; Reperfusion Injury; Respiration; Respiratory Function Tests; Respiratory Rate; Respiratory Sounds; Retrospective Studies; rho GTP-Binding Proteins; Risk Assessment; Risk Factors; RNA; RNA, Messenger; RNA, Ribosomal, 16S; Robotic Surgical Procedures; Running; Rural Population; Saccharomyces cerevisiae; Salpingectomy; Sarcopenia; SARS-CoV-2; Seeds; Semen; Sensitivity and Specificity; Sepsis; Shock, Septic; Signal Transduction; Silicon Dioxide; Silver; Sirtuin 1; Skin Neoplasms; Sleep Apnea, Obstructive; Soil; Spain; Spectrum Analysis, Raman; Sperm Retrieval; Spermatozoa; Spirometry; Staphylococcus aureus; STAT3 Transcription Factor; Stereoisomerism; Sterilization, Tubal; Stroke Volume; Sulfadiazine; Sulfites; Superoxide Dismutase; Surface Plasmon Resonance; tau Proteins; Testis; Testosterone; Thioredoxin-Disulfide Reductase; Thyroid Neoplasms; Thyroidectomy; Trans-Activators; Transcription Factor AP-1; Treatment Outcome; Triazoles; Triclosan; Trifluridine; Tumor Microenvironment; Tumor Necrosis Factor-alpha; United States; Uracil; Vagina; Vegetables; Ventricular Function, Left; Ventricular Pressure; Vibrio cholerae; Vietnam; Virulence; Vital Capacity; Vitrification; Walking; Water; Water Pollutants, Radioactive; Whole Genome Sequencing; Wind; YAP-Signaling Proteins; Zeolites; Zinc Oxide | 2023 |
Combination of serum markers related to several mechanisms in Alzheimer's disease.
Topics: Adult; Aged; Aged, 80 and over; Aging; alpha 1-Antichymotrypsin; Alzheimer Disease; Analysis of Variance; Biomarkers; Chi-Square Distribution; Cholesterol; Cysteine; Female; Follow-Up Studies; Humans; Hydroxycholesterols; Interleukin-6; Logistic Models; Male; Middle Aged; Neurodegenerative Diseases; Parkinson Disease; Reference Values; Serum; Sterols | 2003 |
39 other study(ies) available for cysteine and Degenerative Diseases, Central Nervous System
Article | Year |
---|---|
A covalent strategy to target intrinsically disordered proteins: Discovery of novel tau aggregation inhibitors.
Topics: Cysteine; Drug Design; Humans; Intrinsically Disordered Proteins; Neurodegenerative Diseases; tau Proteins; Tauopathies | 2022 |
In situ Raman spectroscopy for real time detection of cysteine.
Topics: Cysteine; Humans; Neurodegenerative Diseases; Spectrum Analysis, Raman | 2022 |
S-Nitrosylation of cathepsin B affects autophagic flux and accumulation of protein aggregates in neurodegenerative disorders.
Topics: Alzheimer Disease; Animals; Cathepsin B; Cysteine; Humans; Mice; Neurodegenerative Diseases; Nitric Oxide; Protein Aggregates; Proteins | 2022 |
Topics: Animals; Chemical and Drug Induced Liver Injury, Chronic; Concanavalin A; Cysteine; Cytokines; Hydrogen Sulfide; Mice; Neurodegenerative Diseases | 2022 |
Relative quantification of sulfenic acids in plasma proteins using differential labelling and mass spectrometry coupled with 473 nm photo-dissociation analysis: A multiplexed approach applied to an Alzheimer's disease cohort.
Topics: Alzheimer Disease; Blood Proteins; Cysteine; Humans; Maleimides; Mass Spectrometry; Neurodegenerative Diseases; Oxidation-Reduction; Peptides; Sulfenic Acids; Sulfhydryl Compounds | 2022 |
Increased cysteine metabolism in PINK1 models of Parkinson's disease.
Topics: Animals; Cysteine; Drosophila melanogaster; Drosophila Proteins; Humans; Induced Pluripotent Stem Cells; Neural Stem Cells; Neurodegenerative Diseases; Parkinson Disease; Protein Kinases; Protein Serine-Threonine Kinases | 2023 |
Didactic approach recounting advances and limitations in novel glutathione and cysteine detection (reduced GSH probe) with mixed coumarin, aldehyde, and phenyl-selenium chemistry.
Topics: Aldehydes; Animals; Coumarins; Cysteine; Fluorescent Dyes; Glutathione; HeLa Cells; Humans; Neurodegenerative Diseases; Selenium | 2020 |
Cysteine 343 in the substrate binding domain is the primary S-Nitrosylated site in protein disulfide isomerase.
Topics: Brain; Cysteine; Humans; Neurodegenerative Diseases; Protein Binding; Protein Disulfide-Isomerases; Protein Folding | 2020 |
Energy metabolism as a regulator of ferroptosis.
Topics: AMP-Activated Protein Kinases; Cysteine; Ferroptosis; Humans; Iron; Lipid Peroxidation; Mitochondria; Neoplasms; Neurodegenerative Diseases; Reactive Oxygen Species; Reperfusion Injury | 2020 |
[Mechanism of glutathione production in neurons].
Topics: Cysteine; Excitatory Amino Acid Transporter 3; Glutathione; Humans; Neurodegenerative Diseases; Neurons | 2021 |
The intrinsic amyloidogenic propensity of cofilin-1 is aggravated by Cys-80 oxidation: A possible link with neurodegenerative diseases.
Topics: Alzheimer Disease; Amino Acid Sequence; Amyloid; Amyloidogenic Proteins; Cofilin 1; Computer Simulation; Cysteine; Humans; Models, Molecular; Mutation; Neurodegenerative Diseases; Oxidation-Reduction; Propensity Score; Protein Aggregation, Pathological; Protein Stability; Protein Unfolding; Sequence Homology, Amino Acid | 2021 |
S-sulfocysteine/NMDA receptor-dependent signaling underlies neurodegeneration in molybdenum cofactor deficiency.
Topics: Animals; Calcium Signaling; Cysteine; Disease Models, Animal; GABAergic Neurons; HEK293 Cells; Humans; Memantine; Metal Metabolism, Inborn Errors; Mice; Neurodegenerative Diseases; Organophosphorus Compounds; Pterins; Receptors, N-Methyl-D-Aspartate; Synapses; Tungsten Compounds | 2017 |
Progressive apraxic agraphia with micrographia presenting as corticobasal syndrome showing extensive Pittsburgh compound B uptake.
Topics: Aged; Agraphia; Aniline Compounds; Apolipoproteins E; Apraxias; Basal Ganglia Diseases; Brain; Cerebral Cortex; Cysteine; Disease Progression; Executive Function; Female; Handwriting; Humans; Image Processing, Computer-Assisted; Intelligence Tests; Neurodegenerative Diseases; Neurologic Examination; Neuropsychological Tests; Organotechnetium Compounds; Positron-Emission Tomography; Radiopharmaceuticals; Reading; Thiazoles; Tomography, Emission-Computed, Single-Photon | 2013 |
Evaluating the anti-neuroinflammatory capacity of raw and steamed garlic as well as five organosulfur compounds.
Topics: Allium; Allyl Compounds; Animals; Cell Line; Chemokine CCL2; Cysteine; Disulfides; Garlic; Inflammation; Interleukin-1beta; Lipopolysaccharides; Mice; Microglia; Neurodegenerative Diseases; NF-kappa B; Nitric Oxide; Plant Extracts; Sulfides; Sulfur Compounds; Tumor Necrosis Factor-alpha | 2014 |
Cysteine cathepsins are essential in lysosomal degradation of α-synuclein.
Topics: alpha-Synuclein; Animals; Brain; Cathepsin B; Cathepsin D; Cathepsin L; Chromatography, Liquid; Circular Dichroism; Cysteine; Humans; Liver; Lysosomes; Mass Spectrometry; Mice; Neurodegenerative Diseases; Parkinson Disease; Peptide Mapping; Peptides; Phospholipids | 2015 |
[The Development of a Normal Database of Elderly People for Use with the Statistical Analysis Software Easy Z-score Imaging System with 99mTc-ECD SPECT].
Topics: Aged; Aged, 80 and over; Brain; Cerebrovascular Circulation; Cerebrovascular Disorders; Cysteine; Databases, Factual; Female; Humans; Image Processing, Computer-Assisted; Male; Neurodegenerative Diseases; Organotechnetium Compounds; Radiopharmaceuticals; Software; Tomography, Emission-Computed, Single-Photon | 2015 |
Leukotriene-mediated neuroinflammation, toxic brain damage, and neurodegeneration in acute methanol poisoning.
Topics: Acute Disease; Bicarbonates; Blood Glucose; Brain; Creatinine; Cysteine; Ethanol; Female; Follow-Up Studies; Formates; Hospitalization; Humans; Hydrogen-Ion Concentration; Inflammation; Lactates; Leukotrienes; Male; Methanol; Middle Aged; Neurodegenerative Diseases; Poisoning; Treatment Outcome | 2017 |
Conformational detection of prion protein with biarsenical labeling and FlAsH fluorescence.
Topics: Alzheimer Disease; Animals; Cysteine; Fluoresceins; Fluorescence; Huntington Disease; Luminescent Measurements; Mice; Neurodegenerative Diseases; Organometallic Compounds; Parkinson Disease; Prion Diseases; Protein Folding; Protein Structure, Secondary; PrPC Proteins; Recombinant Proteins | 2009 |
Antioxidant strategy to rescue synaptosomes from oxidative damage and energy failure in neurotoxic models in rats: protective role of S-allylcysteine.
Topics: Animals; Antioxidants; Brain; Corpus Striatum; Cysteine; Disease Models, Animal; Dyskinesia, Drug-Induced; Lipid Peroxidation; Male; Mitochondria; Neurodegenerative Diseases; Neurons; Neuroprotective Agents; Nitro Compounds; Oxidative Stress; Propionates; Quinolinic Acid; Rats; Rats, Wistar; Synaptosomes; Time Factors | 2010 |
Oxr1 is essential for protection against oxidative stress-induced neurodegeneration.
Topics: Animals; Cerebellum; Cysteine; Disease Models, Animal; Humans; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Mutant Strains; Neurodegenerative Diseases; Neurons; Orexin Receptors; Oxidative Stress; Receptors, Neuropeptide; Sequence Deletion | 2011 |
PSP as distinguished from CBD, MSA-P and PD by clinical and imaging differences at an early stage.
Topics: 3-Iodobenzylguanidine; Aged; Aged, 80 and over; Basal Ganglia; Cerebral Cortex; Cerebrovascular Circulation; Cysteine; Diagnosis, Differential; Female; Humans; Male; Middle Aged; Multiple System Atrophy; Neurodegenerative Diseases; Organotechnetium Compounds; Parkinson Disease; Parkinsonian Disorders; Radiopharmaceuticals; Supranuclear Palsy, Progressive; Tomography, Emission-Computed, Single-Photon | 2011 |
Molecular mechanism of oxidation-induced TDP-43 RRM1 aggregation and loss of function.
Topics: Amino Acid Sequence; Conserved Sequence; Cysteine; DNA-Binding Proteins; Humans; Models, Molecular; Molecular Sequence Data; Neurodegenerative Diseases; Oxidation-Reduction; Protein Denaturation; Protein Structure, Secondary; Protein Structure, Tertiary; Recombinant Proteins | 2013 |
Brain perfusion SPECT in patients with corticobasal degeneration: analysis using statistical parametric mapping.
Topics: Aged; Basal Ganglia; Basal Ganglia Diseases; Brain Mapping; Case-Control Studies; Cerebral Cortex; Cerebrovascular Circulation; Cysteine; Female; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neurodegenerative Diseases; Organotechnetium Compounds; Radionuclide Angiography; Radiopharmaceuticals; Tomography, Emission-Computed, Single-Photon | 2003 |
Structure of membrane-bound alpha-synuclein studied by site-directed spin labeling.
Topics: alpha-Synuclein; Amino Acid Sequence; Cell Membrane; Cysteine; Electron Spin Resonance Spectroscopy; Humans; Molecular Sequence Data; Nerve Tissue Proteins; Neurodegenerative Diseases; Protein Structure, Secondary; Spin Labels; Synucleins | 2004 |
Novel multifunctional neuroprotective iron chelator-monoamine oxidase inhibitor drugs for neurodegenerative diseases: in vitro studies on antioxidant activity, prevention of lipid peroxide formation and monoamine oxidase inhibition.
Topics: Animals; Antioxidants; Cell Survival; Culture Media, Serum-Free; Cysteine; Designer Drugs; Hydroxyl Radical; Hydroxyquinolines; Iron Chelating Agents; Lipid Peroxidation; Monoamine Oxidase Inhibitors; Neurodegenerative Diseases; Neuroprotective Agents; Oxidopamine; PC12 Cells; Piperazines; Rats | 2005 |
Amyloid-beta induces disulfide bonding and aggregation of GAPDH in Alzheimer's disease.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Amyloid beta-Peptides; Animals; Cell Line; Cell Nucleus; Cysteine; Cytoplasm; Cytosol; Detergents; Digitonin; Disulfides; Dithiothreitol; Electrophoresis, Gel, Two-Dimensional; Electrophoresis, Polyacrylamide Gel; Female; Glyceraldehyde-3-Phosphate Dehydrogenase (Phosphorylating); Glycolysis; Humans; Hydrogen Peroxide; Immunoblotting; Male; Mice; Mice, Transgenic; Models, Biological; Neurodegenerative Diseases; Neurons; Oxidants; Oxidation-Reduction; Polymorphism, Genetic; Protein Isoforms; Rats; Reactive Oxygen Species; Risk; Time Factors | 2005 |
ATPase activity of p97/valosin-containing protein is regulated by oxidative modification of the evolutionally conserved cysteine 522 residue in Walker A motif.
Topics: Adaptor Proteins, Vesicular Transport; Adenosine Triphosphatases; Amino Acid Motifs; Amino Acid Sequence; Animals; Cell Cycle Proteins; Cell Line; Cysteine; Cystic Fibrosis Transmembrane Conductance Regulator; Dithiothreitol; DNA, Complementary; Dose-Response Relationship, Drug; Endoplasmic Reticulum; Evolution, Molecular; Flow Cytometry; Gene Deletion; Glutathione; Humans; Intracellular Signaling Peptides and Proteins; Molecular Sequence Data; Mutation; Neurodegenerative Diseases; Oxidative Stress; Oxygen; Phenotype; Protein Binding; Proteins; Recombinant Proteins; Sequence Homology, Amino Acid; Threonine; Ubiquitin; Valosin Containing Protein | 2005 |
Rapidly progressive neurodegeneration in a case with the 7472insC mutation and the A7472C polymorphism in the mtDNA tRNA ser(UCN) gene.
Topics: Adult; Base Sequence; Brain; Cysteine; Disease Progression; DNA Mutational Analysis; DNA, Mitochondrial; Female; Humans; Magnetic Resonance Imaging; Microscopy, Electron, Transmission; Muscles; Mutation; Neurodegenerative Diseases; Polymorphism, Genetic; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; RNA, Transfer, Ser | 2006 |
[A case of corticobasal degeneration that progressed from primary progressive aphasia].
Topics: Aged; Aphasia, Primary Progressive; Basal Ganglia Diseases; Brain; Cerebral Cortex; Cysteine; Female; Humans; Magnetic Resonance Imaging; Neurodegenerative Diseases; Neuropsychological Tests; Organotechnetium Compounds; Tomography, Emission-Computed, Single-Photon | 2005 |
Runaway domain swapping in amyloid-like fibrils of T7 endonuclease I.
Topics: Amyloid; Cysteine; Deoxyribonuclease I; Dimerization; Disulfides; Models, Molecular; Mutation; Neurodegenerative Diseases; Protein Structure, Secondary; Protein Structure, Tertiary | 2006 |
S-nitrosylated protein-disulphide isomerase links protein misfolding to neurodegeneration.
Topics: Alzheimer Disease; Animals; Binding Sites; Cell Line; Cysteine; Endoplasmic Reticulum; Humans; Molecular Chaperones; N-Methylaspartate; Neurodegenerative Diseases; Nitric Oxide; Parkinson Disease; Proteasome Endopeptidase Complex; Proteasome Inhibitors; Protein Disulfide-Isomerases; Protein Folding; Receptors, G-Protein-Coupled; Sulfhydryl Compounds; Ubiquitin | 2006 |
Strategies for dissecting genetic-environmental interactions in neurodegenerative disorders.
Topics: Adult; Age Factors; Age of Onset; Aged; Aged, 80 and over; Aging; alpha 1-Antitrypsin; Analysis of Variance; Apolipoprotein E4; Apolipoproteins E; Chi-Square Distribution; Cysteine; DNA Mutational Analysis; Environment; Female; Gene Frequency; Genetic Predisposition to Disease; Hemochromatosis; Humans; Male; Middle Aged; Mutation; Neurodegenerative Diseases; Phenotype; Retrospective Studies; Tryptophan | 2006 |
Assessing whole brain perfusion changes in patients with REM sleep behavior disorder.
Topics: Aged; Brain; Brain Stem; Cerebral Arteries; Cerebral Cortex; Cerebrovascular Circulation; Corpus Striatum; Cysteine; Female; Humans; Male; Middle Aged; Neurodegenerative Diseases; Organotechnetium Compounds; Parkinson Disease; Polysomnography; Predictive Value of Tests; Prognosis; REM Sleep Behavior Disorder; Tomography, Emission-Computed, Single-Photon | 2006 |
Folate and methylation status in relation to phosphorylated tau protein(181P) and beta-amyloid(1-42) in cerebrospinal fluid.
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Amyloid beta-Peptides; Biomarkers; Cysteine; Female; Folic Acid; Humans; Male; Methylation; Middle Aged; Nervous System Diseases; Neurodegenerative Diseases; Peptide Fragments; Phosphorylation; S-Adenosylhomocysteine; tau Proteins; Vitamin B 12 | 2007 |
Form and dimensions of aggregates dictate cytotoxicities of Danish dementia peptides.
Topics: Adaptor Proteins, Signal Transducing; Amyloid; Cell Line; Cysteine; Dementia; Humans; Membrane Glycoproteins; Membrane Proteins; Microscopy, Atomic Force; Neurodegenerative Diseases; Neurons; Oxidation-Reduction; Peptides, Cyclic; Protein Conformation; Spectroscopy, Fourier Transform Infrared | 2008 |
Improvement of brain SPECT by stabilization of Tc-99m-HMPAO with methylene blue or cobalt chloride. Comparison with Tc-99m-ECD.
Topics: Adult; Aged; Aged, 80 and over; Brain; Cerebrovascular Disorders; Cobalt; Cysteine; Depression; Drug Stability; Female; Humans; Male; Methylene Blue; Middle Aged; Neurodegenerative Diseases; Organotechnetium Compounds; Radiopharmaceuticals; Scalp; Sensitivity and Specificity; Sleep Apnea Syndromes; Technetium Tc 99m Exametazime; Tomography, Emission-Computed, Single-Photon | 1999 |
Iron on the brain.
Topics: Animals; Axons; Biological Transport; Brain; Cysteine; Disease Progression; Ferritins; Humans; Iron; Iron-Regulatory Proteins; Iron-Sulfur Proteins; Mice; Mutation; Neurodegenerative Diseases; Phosphotransferases (Alcohol Group Acceptor); RNA-Binding Proteins | 2001 |
Peroxynitrite-induced tyrosine nitration and inhibition of protein kinase C.
Topics: Animals; Brain; Cysteine; Isoenzymes; Male; Neurodegenerative Diseases; Nitrates; Nitric Oxide Donors; Nitroprusside; Nitroso Compounds; Oxidants; Oxidation-Reduction; Penicillamine; Protein Kinase C; Protein Kinase C beta; Protein Kinase C-alpha; Rats; Rats, Sprague-Dawley; S-Nitrosothiols; Tissue Extracts; Tyrosine | 2001 |
Aminopeptidase N mediates the utilization of the GSH precursor CysGly by cultured neurons.
Topics: Animals; CD13 Antigens; Cells, Cultured; Central Nervous System; Cysteine; Dipeptides; DNA, Complementary; Fetus; Glutathione; Glycine; Immunohistochemistry; Neurodegenerative Diseases; Neurons; Oxidative Stress; Rats; Rats, Wistar; Reactive Oxygen Species; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger | 2001 |